Kinetic mechanism of dopamine transporter interaction with 1-(2-(bis-(4-fluorophenyl)methoxy)ethyl)-4-(3-phenylpropyl)piperazine (GBR 12909)

被引:6
|
作者
Stepanov, Vladimir [1 ]
Jarv, Jaak [1 ]
机构
[1] Univ Tartu, Inst Chem, EE-51014 Tartu, Estonia
关键词
Dopamine transporter; Transporter inhibitor; GBR12909; PE21; Ligand binding mechanism; Ligand binding kinetics; Isomerisation;
D O I
10.1016/j.neuint.2008.09.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interaction of piperazine-based dopamine transporter inhibitor GBR12909 with rat dopamine transporters has been Studied by means of competition kinetics analysis, employing [(3)H]PE21 as the reporter ligand. It has been found that GBR12909 is capable of inducing so-called "slow isomerization step" upon binding to DAT, probably consisting of a conformational change in the transporter protein. The mechanism exhibited by GBR12909 appears to be similar to the mechanism ofPE21 that has been reported earlier and also confirms previous observations for GBR12783 made by Do-Rego and co-workers using dopamine uptake data. it appears that the isomerization phenomenon previously described for PE21 is not limited to tropane-based DAT inhibitors, but is,in fact,a general property of dopamine transporterprotein, similar to "isomerization" process reported previously for G-protein Coupled receptors. The rapid first step of association of the GBR 12909 is characterized by the equilibrium constant K(L) = 34 +/- 11 nM and the second slow step by k(i) = 0.033 +/- 0.005 s(-1). (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:370 / 373
页数:4
相关论文
共 50 条
  • [31] Synthesis of (S)-2-β-carboalkoxy-3-α-[bis(4-fluorophenyl)methoxy]tropanes and binding at the dopamine transporter.
    Zou, MF
    Belov, Y
    Agoston, G
    Kopajtic, T
    Katz, JL
    Newman, AH
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U16 - U16
  • [32] A concise synthesis of (S)-(+)-1-(4-{2-[bis(4-fluorophenyl)methoxy]-ethyl}piperazin-1-yl)-2-phenylpropan-2-ol dimaleate
    Prisinzano, T
    Hsin, LW
    Folk, JE
    Flippen-Anderson, JL
    George, C
    Jacobson, AE
    Rice, KC
    TETRAHEDRON-ASYMMETRY, 2003, 14 (21) : 3285 - 3289
  • [33] Potent and selective ligands for the dopamine transporter (DAT): Structure-activity relationship studies of novel 4-[2-(diphenylmethoxy)ethyl]-1-(3-phenylpropyl)piperidine analogues
    Dutta, AK
    Coffey, LL
    Reith, MEA
    JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (05) : 699 - 705
  • [34] Crystal structure, analysis of a bioactive piperazine analog: 1-[Bis-(4-fluorophenyl)-methyl]-4-methane sulfonyl piperazine
    Naveen, S.
    Sridhar, M. A.
    Prasad, J. Shashidhara
    Sadashiva, C. T.
    Chandra, J. N. Narendra Sharath
    Rangappa, K. S.
    MOLECULAR CRYSTALS AND LIQUID CRYSTALS, 2007, 469 (89-97) : 89 - 97
  • [35] In vivo evaluation of [123I]-4-(2-(bis(4-fluorophenyl)methoxy)ethyl)-1-(4-iodobenzyl)piperidine, an iodinated SPECT tracer for imaging the P-gp transporter
    De Bruyne, Sylvie
    Wyffels, Leonie
    Boos, Terrence L.
    Staelens, Steven
    Deleye, Steven
    Rice, Kenner C.
    De Vos, Filip
    NUCLEAR MEDICINE AND BIOLOGY, 2010, 37 (04) : 469 - 477
  • [36] CHARACTERIZATION OF BINDING OF [3H]GBR 12935 (1-[2-(DIPHENYLMETHOXY)ETHYL]-4-(3-PHENYLPROPYL)-PIPERAZINE) TO MEMBRANES AND TO SOLUBILIZED MEMBRANE EXTRACTS FROM TERMINAL FIELD REGIONS OF MESOLIMBIC, MESOCORTICAL AND NIGROSTRIATAL DOPAMINE PATHWAYS
    IZENWASSER, S
    WERLING, LL
    ROSENBERGER, JG
    COX, BM
    NEUROPHARMACOLOGY, 1990, 29 (11) : 1017 - 1024
  • [37] HPLC ANALYSIS OF FLUNARIZINE (FLU),(E)-1-[BIS(4-FLUOROPHENYL)METHYL] -4- (3-PHENYL -2- PROPENYL) PIPERAZINE, IN EPILEPTIC PATIENTS
    TORCHIN, CD
    KAPETANOVI, IM
    YONEKAWA, WD
    KUPFERBERG, HJ
    FEDERATION PROCEEDINGS, 1987, 46 (03) : 709 - 709
  • [38] Measurement of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-hydroxy-3-phenylpropyl) piperazine and its anti-cocaine prodrug decanoate ester in rhesus monkey plasma using HPLC-fluorescence detection and in vitro metabolism study on the prodrug.
    Bi, D
    Helbling, N
    Cherstniakova, SA
    Fuller, DR
    Anderson, LW
    Glowa, JR
    Cantilena, LR
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P27 - P27
  • [39] 3-{2-[Bis-(4-fluorophenyl)methoxy]ethyl}-6-substituted-3,6-diazabicyclo[3.1.1]heptanes as novel potent dopamine uptake inhibitors
    Loriga, Giovanni
    Ruiu, Stefania
    Manca, Ilaria
    Murineddu, Gabriele
    Dessi, Christian
    Pani, Luca
    Pinna, Gerard A.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (11) : 3748 - 3755
  • [40] Evidence for the sequential formation of two complexes between an uptake inhibitor, GBR 12783 [1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl-2-propenyl)piperazine], and the neuronal transporter of dopamine
    Do-Régo, JC
    Hue, H
    Costentin, J
    Bonnet, JJ
    JOURNAL OF NEUROCHEMISTRY, 1999, 72 (01) : 396 - 404